Abstract

Background: There is conflicting evidence for the benefit of adjuvant chemotherapy following resection of distal cholangiocarcinoma (dCCA), especially for node-negative (N0) resections. We aimed to evaluate the association of adjuvant chemotherapy with survival after surgical resection of dCCA.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call